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Objectives: Considering sensory stimulation programs (SSP) as a treatment for
disorders of consciousness is still debated today. Previous studies investigating
its efficacy were affected by various biases among which small sample size and
spontaneous recovery. In this study, treatment-related changes were assessed using
time-series design in patients with disorders of consciousness (i.e., vegetative state—VS
and minimally conscious state—MCS).
Methods: A withdrawal design (ABAB) was used. During B phases, patients
underwent a SSP (3 days a week, including auditory, visual, tactile, olfactory, and
gustatory stimulation). The program was not applied during A phases. To assess
behavioral changes, the Coma Recovery Scale-Revised (CRS-R) was administered by
an independent rater on a weekly basis, across all phases. Each phase lasted 4 weeks.
In a subset of patients, resting state functional magnetic resonance imaging (fMRI) data
were collected at the end of each phase.
Results: Twenty nine patients (48 ± 19 years old; 15 traumatic; 21 > a year post-injury;
11 VS and 18 MCS) were included in our study. Higher CRS-R total scores (medium
effect size) as well as higher arousal and oromotor subscores were observed in the B
phases (treatment) as compared to A phases (no treatment), in the MCS group but not
in the VS group. In the three patients who underwent fMRI analyses, a modulation of
metabolic activity related to treatment was observed in middle frontal gyrus, superior
temporal gyrus as well as ventro-anterior thalamic nucleus.
Conclusion: Our results suggest that SSP may not be sufficient to restore
consciousness. SSP might nevertheless lead to improved behavioral responsiveness in
MCS patients. Our results show higher CRS-R total scores when treatment is applied,
and more exactly, increased arousal and oromotor functions.
Keywords: brain injuries, consciousness, persistent vegetative state, minimally conscious state, sensory
stimulation
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INTRODUCTION
Amantadine is till now the only treatment that has shown its
efficacy in patients with severe brain injury (1). Finding new
ways to treat patients recovering from disorders of consciousness
is therefore one of the biggest challenge facing clinicians (2).
Patients can stay during months to years in disorders of
consciousness such as vegetative state (which is characterized
by the presence of arousal but the absence of awareness) or
minimally conscious state (which is characterized by the presence
of fluctuating but reproducible signs of consciousness but an
absence of reliable communication), leading to a financial and
ethical conundrum for the families (3, 4). Sensory stimulation
programs (SSP) have been the most studied treatment in the
neurorehabilitation field (5). These programs are based on the
idea that an enriched environment benefits brain plasticity and
improves the recovery of injured brains (6).
Rosenzweig and coworkers who were the first to introduce
“environmental enrichment” in the field of animal research four
decades ago showed that the morphology and physiology of
the brain can be altered by modifying the quality and intensity
of environmental stimulation (7, 8). Enriched environment has
been associated with changes in cortical thickness (9, 10), changes
in neurons size, number and connections (11–16). Exposure
to such environment has shown to be beneficial following
experimental brain lesions (17–19), particularly, in terms of
recovery of cognitive (e.g., learning and memory) and motor
functions (20–22). Enriched environment following brain injury
has also shown additional beneficial effects such as decreasing
lesion size or enhancing dendritic branching (6, 23–25).
Based on animal research, the Institutes for the Achievement
of Human Potential (IAHP) have introduced SSP in the field
of neurorehabilitation. Despite the lack of scientific evidence
in human subjects, these programs were supported on the
principle that they could enhance the rehabilitative process by
avoiding environmental deprivation and promoting synaptic
reinnervation, thus accelerating the recovery from disorders of
consciousness in severely brain injured patients (26). Numerous
studies have investigated SSP in patients with disorders of
consciousness [for a review see: (5, 27, 28)]. While Padilla (5)
concluded that the current literature provided strong evidence
that multimodal sensory stimulation improves arousal and
enhances clinical outcomes for patients in a coma or persistent
vegetative state, both Meyer (28) and Cossu (27) reported that
there was conflicting evidence regarding the clinical relevance
and the benefit of sensory stimulation in patients recovering
from coma. Most studies are, indeed, affected by various
methodological biases such as, among others, poor description of
the disorders of consciousness, poor validity, and/or sensitivity of
the outcome measure, small sample size as well as spontaneous
recovery. Indeed, these studies were mostly performed in the
acute stage, a period during which spontaneous recovery has
the highest probability to occur. Interestingly, several recent
studies investigated whether the improvements observed after
SSP exceeded spontaneous recovery using a time-series design.
However, they all included a small number of patients (n < 15)
(29–31). Finally, neuroimaging data was collected in a subset
of patients. Only one study recently investigated the changes in
brain activity related to treatment. Pape and coworkers examined
the effects of a unimodal stimulation program in 15 patients
using familiar auditory stimulation and found higher activation
in the language network in the treated group as compared to
the control group, suggesting that coupling behavioral measures
with neuroimaging may help to understand what impact sensory
stimulation has on the recovering brain (32).
Therefore, the aim of this study was to assess the impact
of SSP on the recovery of consciousness (as measured by the
Coma Recovery Scale-Revised) and to determine treatment-
related changes using a time-series design in a group of patients
with disorders of consciousness (i.e., VS and MCS).
METHODS
Inclusion/Exclusion Criteria
Severely brain injured patients diagnosed as being in a vegetative
state (VS) (3) or in a minimally conscious state (MCS) (4)
were recruited from the Rehabilitation Center for Brain Damage
of Wujing Hospital (Hangzhou, China) and the Research in
Advanced Neurorehabilitation of S. Anna Institute (Crotone,
Italy). Patients were only followed during their stay in the
inpatient rehabilitation unit. Patients were included in the study
if they (a) were at least 18 years old, (b) were at least a
month post-injury, and (c) presented periods of spontaneous
eye opening. Traumatic and non-traumatic etiologies were
included in this study. Patients were excluded if they had (a) a
documented history of prior brain injury, (b) premorbid history
of uncorrected visual or hearing impairments, (c) premorbid
history of developmental, psychiatric, or neurologic illness
resulting in documented functional disability up to the time
of the injury, (d) acute illness, (e) emerged from MCS during
the first A phase as assessed by the Coma Recovery Scale—
Revised (33), and (f) medical complications during the study.
Information regarding patients’ comorbidities and education
were not collected. This study was carried out in accordance with
the recommendations of the ethics committee of the Hangzhou
Normal University (Hangzhou, China) and the S. Anna Institute
(Crotone, Italy). The study was approved by the ethics committee
of each participating center. Written informed consent was
obtained from the patients’ legal surrogate in accordance with the
Declaration of Helsinki.
Behavioral Data Acquisition and Analyses
Procedure
Time series design was chosen to address previous criticisms on
spontaneous recovery (34). Indeed, one advantage of this design
is to compare baselines to treatment and, therefore, to measure
how the presence/absence of the target treatment modulates the
outcome measure within each participant. An ABAB withdrawal
design (where A = baseline and B = treatment) was preferred
to an AB or ABA design since it provided an opportunity to
repeatedly collect data on the relationship between the treatment
and the outcomes of interest. Each phase of this ABAB design
lasted 4 weeks, as previously used (27, 29). During A phases,
no SSP was administered, the patients only received until 3 h a
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day for 5 days a week of comprehensive rehabilitation including
nursing care as well as physical therapy, respiratory therapy and
speech therapy. During B phases, a SSP (described below) was
also administered 3 times a week (i.e., Monday, Wednesday, and
Friday; twice a day), as agreed with the medical staff.
The Coma Recovery Scale—Revised (CRS-R) (33) was chosen
as our outcome measure and was administered once weekly (i.e.,
Saturday) for the full length of the study (i.e., across all phases)
to assess changes in behavioral responsiveness. The Chinese and
Italian translations of the scale were used in this study (35, 36).
The CRS-R was designed to differentiate VS from MCS patients
and is recommended by the American Congress of Rehabilitation
Medicine to assess patients with disorders of consciousness
(37). It consists of 23 hierarchically-arranged items divided
into six subscales assessing auditory, visual, motor, oromotor,
communication, and arousal functions. The rater performing the
CRS-R assessments was not involved in the administration of the
SSP and was not aware of the study design (i.e., ABAB). In each
center, the same rater assessed the patients every week.
SSP
The administration of SSP corresponds to the B phases of our
procedure. Based on the literature, we opted for a multi-sensory
stimulation program including auditory, visual, tactile, olfactory,
and gustatory stimuli (5, 28). Familiar stimulations were used
since it has been shown that there is a higher probability
to observe an improved behavioral response when emotional
stimuli are presented (5, 38). Each stimulation was administered
three times, on the patient’s right and left side alternatively
(inter-stimulus interval of 20 s). The order in which sensory
stimulations were applied was randomized for each session. The
program lasted around 20min per session.
The program included the following stimulation: (a) Visual
stimulation. A picture of the family member with whom the
patient had the closest relationship before the injury was
presented to the patient. If not possible to obtain, a picture with a
high positive valence (valence of 8 according to the International
Affective Picture System) was used (39). The picture was slowly
moved 45 degrees to the right and left of the vertical midline
and 45 degrees above and below the horizontal midline. (b)
Auditory stimulation. The patient’s favorite music before the
injury was chosen. If not possible to obtain, classical music
was used. (c) Tactile stimulation. Fingertips were used to apply
firm pressure down the patient’s arm, from the shoulder to
the wrist. Areas with fractures as well as skin or muscular
lesions were not stimulated. (d) Olfactory stimulation. The smell
the patient preferred before the injury (or, by default, vanilla
concentrate) was presented underneath the patient’s nose. In case
of tracheotomy, the entrance of the cannula was covered. (e)
Gustatory stimulation. The flavor the patient preferred before the
injury (or, by default, vanilla concentrate) was chosen. A stick
soaked of this flavor was introduced into the patient’s mouth.
Several recommendations had to be followed such as: applying
the treatment while the patients were in a wakeful state with eyes
open in a setting with minimal ambient noise and respecting a
30min rest before each session (i.e., absence of nursing care).
Statistical Analyses
A mixed-design ANCOVA was performed on the CRS-R total
scores with phase (ABAB) and week (1-2-3-4) as within-subject
factors, diagnosis (VS vs. MCS) and etiology (traumatic vs. non-
traumatic) as between-subjects factors, and time since injury as
a covariate. The effect size was estimated, for each significant
result, using a partial-η2 statistic (small: ηp
2 ≥ 0.01; medium:
ηp
2 ≥ 0.06; large: ηp
2 ≥ 0.14) (40). Planned comparisons were
intended to be used to compare CRS-R total scores during B
phases (treatment) vs. A phases (no treatment) for both VS and
MCS groups but also within each group, separately. Wilcoxon
tests were performed to compare CRS-R mean subscores during
A phases and B phases for both VS and MCS groups but also
within each group, separately.
fMRI Data Acquisition and Analyses
Neuroimaging data were acquired at one of the two centers which
had Magnetic Resonance Imaging (MRI), the Rehabilitation
Center for BrainDamage ofWujingHospital (Hangzhou, China).
Using a 1.5 Tesla Siemens Magnetom Essenza MRI system
(Siemens AG, Munich, Germany). Resting state functional MRI
(fMRI) data were collected in a subset of patients at the end
of each phase (on the fourth week) to assess the effects of the
treatment on brain activity. Inclusion criteria were: stability of
vital parameters and absence of contra-indications for entering
the MRI environment. The preprocessed data was used to
calculate, on a single-subject basis, the Amplitude of Low
Frequency Fluctuations (ALFF) across the whole brain (band
frequency of interest: 0.01–0.1Hz). Results were Z-scored across
the full brain. Group data was analyzed using a repeatedmeasures
ABAB design, to assess the effect of phase on the ALFF maps. For
more information regarding the fMRI acquisition and analyses,
see Supplementary Material.
RESULTS
Participants
Twenty nine patients (48 ± 19 years old; 19 men; age range:
20–79 years) were included in this study. The etiology of brain
injury was traumatic (n = 15), anoxic (n = 5), ischemic stroke
(n = 5), hemorrhagic (n = 3), or metabolic (n = 1). The time
since injury was more than a year for 21 patients (1.04–10.7
years) and less than a year for eight patients (41–348 days).
According to CRS-R scores (Table 1), 11 patients presented
a stable diagnosis of VS and 18 patients presented a stable
diagnosis of MCS during the first A phase. Eighteen patients
were recruited at the Rehabilitation Center for Brain Damage
of Wujing Hospital (Hangzhou, China) and 11 at Research in
AdvancedNeurorehabilitation, S. Anna Institute (Crotone, Italy).
To test differences in patients’ population among both centers,
T-tests and Chi-squares were used to compare variables that
are known to impact patients’ outcome (2): time since injury,
etiology (i.e., traumatic vs. non-traumatic) and diagnosis (i.e.,
VS vs. MCS). We did not find any difference between centers
(t(27) = 1.53, p = 0.14; χ
2
(1)
= 0.96, p = 0.33; and, χ2
(1)
=
1.65, p = 0.2, respectively). The medications most frequently
administered included; antispastics, anticonvulsants, anti-acid,
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TABLE 1 | Demographic data for minimally conscious (MCS) and vegetative (VS)
patients.
Patient Etiology TSI CRS-R AF VF MF OF C Ar
MCS 1 Traumatic 4.8 y 13 2 3 5 1 0 2
MCS 2 Traumatic 3.2 y 10 2 3 2 1 0 2
MCS 3 Traumatic 4.48 y 10 0 3 5 0 0 2
MCS 4 Stroke 2.87 y 13 2 3 4 2 0 2
MCS 5 Stroke 2.93 y 10 2 3 2 1 0 2
MCS 6 Traumatic 2.93 y 9 2 3 2 1 0 1
MCS 7 Stroke 2.91 y 15 4 5 2 1 1 2
MCS 8 Anoxic 1.04 y 19 4 5 5 2 1 2
MCS 9 Traumatic 2.4 y 10 2 3 2 1 0 2
MCS 10 Traumatic 5.52 y 13 2 3 5 1 0 2
MCS 11 Hemorrhage 10.07m 9 1 3 2 1 0 2
MCS 12 Stroke 3.53m 13 3 1 5 2 0 2
MCS 13 Traumatic 1.27y 9 2 1 2 2 0 2
MCS 14 Traumatic 5.47m 8 2 2 2 0 0 2
MCS 15 Traumatic 11.6m 14 3 4 4 1 0 2
MCS 16 Traumatic 6.9m 5 0 0 4 1 0 0
MCS 17 Traumatic 2.19 y 11 2 3 2 2 0 2
MCS 18 Anoxic 2.42 y 12 1 3 5 1 0 2
VS 1 Traumatic 3.95 y 8 1 1 2 2 0 2
VS 2 Traumatic 1.45 y 7 1 1 2 1 0 2
VS 3 Hemorrhage 1.09 y 6 2 0 2 1 0 1
VS 4 Hemorrhage 1.81 y 7 2 0 2 1 0 2
VS 5 Traumatic 7.23m 6 0 0 2 2 0 2
VS 6 Metabolic 5.36 y 7 2 0 2 1 0 2
VS 7 Anoxic 3.77m 7 1 1 2 2 0 1
VS 8 Stroke 1.28 y 7 1 0 2 2 0 2
VS 9 Traumatic 1.33 y 7 1 1 2 1 0 2
VS 10 Anoxic 1.37m 8 2 1 2 1 0 2
VS 11 Anoxic 10.7 y 7 1 0 2 2 0 2
TSI, Time Since Injury (y = years/m = months); CRS-R, total scores for the Coma
Recovery Scale-Revised (AF, Auditory Function; VF, Visual Function; MF, Motor Function;
OF, Oromotor Function; C, communication; Ar, Arousal). The highest CRS-R total scores
(and its subscores) on the first A phase (baseline) are mentioned.
laxatives, analgesics, mucolytics, vitamins, and supplements.
None of our patients received Amantadine (or Zolpidem), which
could have an impact on the patient’s consciousness recovery
(1, 2).
Behavioral Results
Using a mixed-design ANCOVA, a main effect of phase (ABAB)
[F(3) = 3.17, p = 0.03] was found. The effect size was found
to be medium (ηp
2 = 0.12). We did not find any interaction
with the time since injury [F(3) = 0.65, p = 0.58], the etiology
(i.e., traumatic vs. non traumatic) [F(3) = 0.36, p = 0.78], or
the diagnosis [F(3) = 1.35, p = 0.26]. We have to note that we
also found a main effect of the diagnosis [F(1) = 39.78, p <
0.001], which is not surprising since this variable (particularly,
being conscious/MCS) is known to impact patients’ general
outcome (41) (Supplementary Material and Figure 1). Using
planned comparisons, we found a significant difference [F(1) =
FIGURE 1 | Changes in CRS-R total scores. This figure illustrates the mean
(bars = 95% confidence intervals) of the CRS-R total scores on treatment
(dark gray) vs. off treatment (light gray) for both vegetative (VS) and minimally
conscious (MCS) groups (A) but also within each group, separately (B).
Asterisks indicate significant results (p < 0.05).
6.98, p = 0.01] between B phases (treatment) and A phases (no
treatment); CRS-R total scores being higher during treatment.
However, when considering the diagnosis, CRS-R total scores
were found to be higher during treatment in MCS patients [F(1)
= 7.18, p = 0.01] but not in VS patients [F(1) = 1.28, p = 0.27]
(Figure 1).
Regarding subscores, higher scores during treatment (B
phases vs. A phases) were only found for the oromotor subscale
(T = 2.73, p = 0.006) and the arousal subscale (T = 2.8, p =
0.005). Such difference was confirmed inMCS patients (T = 2.07,
p = 0.04 and T = 2.22, p = 0.03, respectively) but not in VS
patients (Table 2).
fMRI Results
fMRI scans were performed across each phase on seven patients.
Patients who exhibitedmotion greater than one voxel (i.e., 3mm)
were excluded from the analysis. Therefore, data of only three
patients (i.e., MCS 7, MCS 8, and VS 11) were considered for
analyses. Because of the small number of patients, group analyses
were performed using a fixed-effects model (42), and significance
was assessed using a non-parametric permutation test (available
in FSL) at a significance level of p < 0.005 uncorrected. Regions
exhibiting significant activations were identified using the MNI
structural atlas, and further specified with the Harvard-Oxford
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TABLE 2 | Results for the Wilcoxon tests performed to compare CRS-R
subscores (average ± standard deviation) during A phases and B phases for both
VS and MCS groups but also within each group, separately.
MCS/VS A phases B phases p
Auditory 1.33 ± 0.71 1.35 ± 0.80 0.95
Visual 1.82 ± 1.39 1.84 ± 1.35 0.64
Motor 2.51 ± 1.11 2.56 ± 1.19 0.57
Oromotor 1.20 ± 0.38 1.34 ± 0.41 0.006*
Communication 0.04 ± 0.16 0.08 ± 0.32 0.18
Arousal 1.74 ± 0.26 1.83 ± 0.19 0.005*
MCS
Auditory 1.49 ± 0.83 1.60 ± 0.88 0.30
Visual 2.63 ± 1.12 2.60 ± 1.08 0.97
Motor 2.94 ± 1.23 3.03 ± 1.28 0.36
Oromotor 1.18 ± 0.45 1.33 ± 0.47 0.04*
Communication 0.07 ± 0.20 0.13 ± 0.40 0.18
Arousal 1.82 ± 0.26 1.91 ± 0.17 0.03*
VS
Auditory 1.07 ± 0.36 0.95 ± 0.43 0.08
Visual 0.49 ± 0.37 0.60 ± 0.62 0.39
Motor 1.82 ± 0.17 1.78 ± 0.35 0.68
Oromotor 1.21 ± 0.24 1.36 ± 0.33 0.07
Communication 0 ± 0 0 ± 0 1
Arousal 1.62 ± 0.21 1.7 ± 0.14 0.08
Significant results are indicated by an asterisk (p < 0.05).
atlas and the ICBM Deep Nuclei Probabilistic atlas (43, 44). The
group ALFF analyses revealed higher activation during treatment
in the right middle frontal gyrus (t = 1.71, p = 0.001; peak
voxel: x = 21, y = 70, z = 54) and right superior temporal
gyrus (t = 1.88, p = 0.001; peak voxel: x = 20, y = 62, z
= 31) as well as the bilateral ventro-anterior thalamic nucleus
(t = 1.26/1.23, p = 0.002/0.003; peak voxels: x = 49/40, y =
59/59, z= 38/35, for the left and right hemispheres, respectively)
(Figure 2).
DISCUSSION
The aim of this study was to assess the impact of SSP on
the recovery of consciousness and to determine treatment-
related changes using a time-series design in patients with
disorders of consciousness (i.e., VS and MCS). Our results
suggest that SSP may not be sufficient to restore consciousness.
However, SSP might lead to improved behavioral responsiveness
in MCS patients. Our results show higher CRS-R total scores
when treatment is applied with increased arousal and oromotor
function but no changes for the other subscales (i.e., visual,
motor, or communication).
Our results showed higher CRS-R total scores when treatment
was applied (B phases) as compared to when treatment
was not applied (A phases) (with a medium effect size).
The time since injury or the etiology did not seem to
have an impact on our dataset. However, patients who were
diagnosed as being in a MCS obtained higher CRS-R total
scores during treatment than off treatment while patients
who were diagnosed as being in a VS did not show such
changes. We should however, nuance our findings since we
did not find an interaction between CRS-R changes through
each phases and diagnosis (VS/MCS) which indicates that the
significant changes that we found for our planned comparison
(when compiling both A phases versus both B phases) are
in fact smaller when each phase is considered separately.
Higher CRS-R subscores were also found during treatment
for the oromotor and arousal subscales but not for the
other subscales (i.e., visual, motor, or communication). These
findings were mainly present in MCS patients (i.e., higher
oromotor and arousal subscores during treatment) but not
in VS patients. We have to mention that even though we
found significant results in two subscales of the CRS-R, we
could not show, because of statistical limitation, that these
changes were significantly higher as compared to the other
subscales. Therefore, specific treatment related improvements in
arousal and verbal functions should be further investigated and
confirmed in the future.
Previous studies using time series and performed in smaller
samples (n < 15) have reported a modulation of behavioral
responses related to treatment based on standardized scales
assessing the level of consciousness (29, 30). Using emotionally
relevant multi-modal stimulation, Di Stefano and coworkers
have found an increased responsiveness in terms of the number
of behaviors but also in terms of complexity, based on the
Wessex Head Injury Matrix (45). Additionally, even though it
did not reach significance, MCS tend to show more behavioral
responsiveness than VS patients similarly to our findings.
The authors also suggested that the use of emotional stimuli
(as used in this study) might have optimized arousal and
facilitates behavioral responsiveness (30). Improved arousal
has also been shown in studies using a controlled design
based on the Glasgow Coma Scale (28, 46, 47). Finally,
recent studies have shown that SSP using emotional stimuli
have a higher likelihood to lead to increased responsiveness
while studies using neuroimaging showed higher metabolic
brain activity in response to self-relevant stimuli (5, 38,
48).
The behavioral changes observed (increased arousal
and oromotor function) also seem to be in line with our
neuroimaging data. Indeed, treatment-related metabolic changes
were observed in the superior temporal gyrus, the middle frontal
gyrus, and the ventral anterior thalamic nucleus. The superior
temporal and middle prefrontal gyri are typically recruited by
a number of cognitive processes including language (49) while
the ventral anterior thalamic nucleus is known to be a major
source of projection to the premotor sections of the frontal
cortex, and is involved in motor planning and speech (50). The
thalamus also plays a key role in arousal and consciousness.
According to the mesocircuit theory, projections from thalamus
to associative cortical areas (including temporal and frontal)
are crucial for sustaining organized behaviors and integrating
information across different regions of cortex (51). Moreover,
the ventral anterior nucleus receives neuronal inputs from
the basal ganglia which seems to serve a critical role in the
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FIGURE 2 | Brain areas with treatment-related metabolic changes. The left side of (A) illustrates, at the group level, areas with treatment-related metabolic changes
which include the right middle frontal gyrus, the right superior temporal gyrus as well as the bilateral ventro-anterior thalamic nucleus (L = left, R = right) (p < 0.005
voxel-wise uncorrected). On the right side of (A), z-scores for each activated area are also reported at each phase (ABAB) for patients MCS 7, MCS 8, and VS 11.
(B) Shows the CRS-R total scores on the last week of each phase (ABAB) for patients MCS 7, MCS 8, and VS 11.
maintenance of behavioral and electrocortical arousal, as well
as wakefulness (52–54). Finally, Pape and coworkers found
higher activation in the superior temporal and prefrontal gyri in
the treated group as compared to the control group, following
an unimodal (familiar auditory) stimulation. Anecdotally, the
authors also observed higher arousal and more vocalizations in
the treated group (32). Besides the neuroimaging modulation
observed, the behavioral results obtained in the patients who
underwent fMRI, particularly, MCS7 and MCS8 (who were
chronic non-traumatic patients; respectively, 2.91 and 1.04
y post injury), also seem to show fluctuations according to
the presence/absence of treatment. VS 11 (who was chronic
non-traumatic patient; 10.7 y post injury) did not show such
fluctuations (but a constant increase which is difficult to interpret
as related to our treatment). This observation is parallel to what
we found at the group level since changes in CRS-R scores
were mainly observed in the MCS group. Nevertheless, we have
to nuance this interpretation since VS 11 had a significantly
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longer time post injury (10 y), which might also explain why we
don’t see changes related to treatment. We also have to stress
that our neuroimaging findings were based on an extremely
small subsample (n = 3), which makes it difficult to formulate
firm conclusions. Nonetheless, except Pape et al. (32), no
studies have reported neuroimaging findings. Such findings
are important since they allow us to start better understanding
the mechanisms of action of a particular treatment, here,
the SSP. We nevertheless do realize that the generalization
of these results is quite limited and that these data are very
preliminary.
Our study aimed to address various methodological biases
existing in previous studies such as poor description of disorders
of consciousness, poor validity, and/or sensitivity of the outcome
measure, small sample size as well as spontaneous recovery.
Patients recruited in this study were assessed and diagnosed
either in a VS or in a MCS based on the CRS-R. The
CRS-R is currently the most validated and sensitive scale
available to perform behavioral assessment in patients with severe
brain injury and to stratify with high accuracy the level of
consciousness (37). On the other hand, time series withdrawal
design was also chosen not only to address the sample size but
also the spontaneous recovery issue. Indeed, withdrawal designs
(here, ABAB) provided a high degree of experimental control
while being relatively straightforward to plan and implement.
Such design allows to repeatedly compare baseline to treatment in
order to measure the outcome with and without the intervention,
and therefore offers a better control for the impact of natural
recovery. Another advantage is that, as compared to controlled
designs, within-subject measures requests no matching processes
and a smaller sample size (since the sample is not divided
between an intervention and a control group). Our study is
the first one to include a large sample (n = 29) using time-
series design, confirming previous preliminary findings (29–31).
Only one recent study using a controlled design included 30
patients per group. Indeed, Salmani et al. (48) evaluated the
effects of SSP including emotional stimulation on the level of
consciousness and showed higher GCS and CRS-R total scores
in the end of the intervention in patients receiving emotional
SSP as compared to neutral SSP, suggesting that family-centered
affective stimulation is more effective in improving the level of
consciousness.
This study has several limitations. First, even though the
time since injury did not seem to influence the behavioral
changes observed during treatment, the majority of our patients
were chronic (21 of 29 patients were more than a year post
injury), decreasing our chances to see spontaneous recovery
but most likely also reducing our chances to see consciousness
improvement. Also, the size of VS (n = 11) and MCS (n =
18) groups did not allow us to explore further the difference of
outcome observed. Our neuroimaging data was collected in a
very small sample limiting the interpretation of our findings. A
double-blinded design was not used in this study. The CRS-R
rater was blinded regarding the ABAB design but knew that the
study was about applying treatment to patients with disorders of
consciousness. The therapist applying the SSP and the patients’
family were not blinded. The aim of the study was not to
determine the time, the frequency, the duration and type of
program (multi-modal, unimodal, or sensory regulation) (47)
requested to optimize the recovery of patients with severe brain
injury. One could argue that the effects observed might be
due to changes in therapy independent from our treatment.
Nevertheless, changes might likely have happened at random
in our sample (n = 29); i.e., it is most likely that not all our
patients stopped or started a therapy at the same time but
rather stopped or started a therapy at different time through
the study. The withdrawal design we used allowed us to look
at behavioral changes that are time locked to treatment as
opposed to random changes in treatment. Besides, the statistics
we used (mixed design ANCOVA) also controls for such bias and
ensures that the effects observed represent a global tendency of
the group (that is time locked to treatment). Our data cannot
speak on whether the presently applied SSP also leads to lasting
changes in level of consciousness and therefore really leads to
lasting rehabilitation benefits (in contrast to short-lived changes
in responsiveness that might vanish as soon as the SSP is
discontinued). Future studies will have to include long term
follow-up in order to answer this important issue. Finally, since a
controlled design was not used, one cannot clearly determine, in
this study, whether improvements are due to specific aspects of
our SSP (such as emotional stimulation) or non-specific aspects
(such as more time devoted to patients, or non-specific arousal
effect).
In conclusion, our study showed a modulation of behavioral
responses in a larger sample using time series design. Our
results suggest that, even if it may not be sufficient to restore
consciousness, SSP might lead to improved behavioral
responsiveness in MCS patients. Combined with other
validated therapeutics (such as Amantadine) (1), SSP might
optimize patients’ recovery. Further investigation is nevertheless
warranted to test this hypothesis.
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